This website uses cookies to enhance the user experience.
21st logo
||
V

VISTIN PHARMA ASA915 157 882

Process industry
Public limited company
Østensjøveien 27 0661 OSLO, Norge

VISTIN PHARMA ASA

Operating
Utvikling, produksjon og salg av legemidler og andre helserelaterte produkter og tjenester. Dette kan også realiseres ved eierskap i andre selskaper.

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Links

Organization

Chairman of the board
Years since formation
11 years
since Mar 24, 2015
Type
Public limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
44,344,592
1 share class
Total number of shareholders
1832
182 companies, 1,650 persons
Belongs to group of

Financials

Annual total result 2025
10,989,000
NOK
Total equity 2025
139,593,000
NOK
Last update: Sep 1, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-
Board Member-
Board Member-
Board Member-
Board Member-
Alternate Member-
Alternate Member-
Alternate Member-
Alternate Member-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-

Top 10 individual shareholders

NameRoleShares
-
11.13 %
indirectly
-
10.79 %
indirectly
-
10.79 %
indirectly
-
2.52 %
indirectly
-
2.21 %
indirectly
-
1.95 %
indirectly
-
1.73 %
directly
-
1.7 %
directly < 0.01 %
indirectly 1.69 %
-
1.67 %
directly 0.05 %
indirectly 1.62 %
Last update: Dec 19, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
I
INTERTRADE SHIPPING AS
Ordinary shares
14,509,280
32.72 %
H
HOLMEN SPESIALFOND
Ordinary shares
4,371,558
9.86 %
P
PACTUM VEKST AS
Ordinary shares
2,991,773
6.75 %
M
MP PENSJON PK
Ordinary shares
1,719,848
3.88 %
T
TIGERSTADEN AS
Ordinary shares
800,000
1.8 %
Ordinary shares
765,700
1.73 %
S
STORKLEIVEN AS
Ordinary shares
751,000
1.69 %
A
AUGUST RINGVOLD AGENTUR AS
Ordinary shares
750,315
1.69 %
L
LUCELLUM AS
Ordinary shares
720,000
1.62 %
I
IVAR LØGES STIFTELSE
Ordinary shares
540,000
1.22 %
S
SURFSIDE HOLDING AS
Ordinary shares
527,960
1.19 %
C
CORTEX AS
Ordinary shares
508,989
1.15 %
S
SANDEN EQUITY AS
Ordinary shares
500,000
1.13 %
D
DNB BANK ASA
Ordinary shares
489,746
1.1 %
D
DELTA AS
Ordinary shares
415,000
0.94 %
G
GINKO AS
Ordinary shares
400,000
0.9 %
M
MELESIO INVEST AS
Ordinary shares
397,110
0.9 %
B
BOOLEAN AS
Ordinary shares
350,000
0.79 %
Ordinary shares
301,658
0.68 %
Ordinary shares
284,040
0.64 %
F
FRENICO AS
Ordinary shares
215,000
0.48 %
N
NORDNET LIVSFORSIKRING AS
Ordinary shares
203,381
0.46 %
O
OVÅ INVEST AS
Ordinary shares
200,000
0.45 %
T
TRULS INVEST AS
Ordinary shares
200,000
0.45 %
H
HJELLEGJERDE INVEST AS
Ordinary shares
200,000
0.45 %
W
WEM INVEST AS
Ordinary shares
186,967
0.42 %
N
NEBBA HOLDING AS
Ordinary shares
182,829
0.41 %
F
Fraternitas A/S
Ordinary shares
180,000
0.41 %
T
TRACK AS
Ordinary shares
179,087
0.4 %
S
SOGNEFJELL AS
Ordinary shares
174,529
0.39 %
H
HEKAMA INVEST AS
Ordinary shares
153,440
0.35 %
F
FATEBURET AS
Ordinary shares
149,800
0.34 %
F
FJORD HOLDING AS
Ordinary shares
148,351
0.33 %
Ordinary shares
140,000
0.32 %
A
AGDES INVEST AS
Ordinary shares
140,000
0.32 %
G
GSH INVEST AS
Ordinary shares
131,000
0.3 %
Ordinary shares
120,710
0.27 %
Ordinary shares
115,003
0.26 %
G
GK INVEST HOLDING AS
Ordinary shares
115,000
0.26 %
J
JOTUNFJELL AS
Ordinary shares
110,076
0.25 %
A
AEL INVEST AS
Ordinary shares
109,486
0.25 %
M
MUSTADGÅRDENE HOLDING AS
Ordinary shares
103,919
0.23 %
Ordinary shares
102,380
0.23 %
Ordinary shares
102,106
0.23 %
L
LUUNA AS
Ordinary shares
100,264
0.23 %
N
NORUMBEGA AS
Ordinary shares
100,000
0.23 %
B
BELE AS
Ordinary shares
100,000
0.23 %
B
BELA AS
Ordinary shares
100,000
0.23 %
Ordinary shares
100,000
0.23 %
F
FOLLUM INVEST AS
Ordinary shares
100,000
0.23 %
H
HAFSTAD INVEST AS
Ordinary shares
96,000
0.22 %
A
AALL KAPITAL AS
Ordinary shares
92,694
0.21 %
K
KLOKKERSVEA AS
Ordinary shares
85,000
0.19 %
Ordinary shares
81,200
0.18 %
Ordinary shares
77,360
0.17 %
C
CHRISHØEG AS
Ordinary shares
75,875
0.17 %
Ordinary shares
75,000
0.17 %
T
TRINITY GROUP AS
Ordinary shares
74,000
0.17 %
Ordinary shares
69,200
0.16 %
Ordinary shares
64,995
0.15 %
Ordinary shares
62,000
0.14 %
Ordinary shares
60,000
0.14 %
Ordinary shares
60,000
0.14 %
Ordinary shares
59,051
0.13 %
Ordinary shares
55,784
0.13 %
Ordinary shares
52,737
0.12 %
H
H RESSEM AS
Ordinary shares
50,410
0.11 %
Ordinary shares
50,120
0.11 %
L
LAL HOLDING AS
Ordinary shares
50,000
0.11 %
Ordinary shares
50,000
0.11 %
Ordinary shares
50,000
0.11 %
A
AASE INVESTERING AS
Ordinary shares
50,000
0.11 %
Ordinary shares
50,000
0.11 %
Ordinary shares
50,000
0.11 %
Ordinary shares
50,000
0.11 %
Ordinary shares
50,000
0.11 %
H
HARMOHNI AS
Ordinary shares
48,311
0.11 %
M
MINGDE AS
Ordinary shares
48,063
0.11 %
Ordinary shares
45,410
0.1 %
E
ENIGMA AS
Ordinary shares
45,120
0.1 %
S
STRIN AS
Ordinary shares
45,000
0.1 %
Ordinary shares
44,573
0.1 %
M
MAGNUS DEN GODE AS
Ordinary shares
44,286
0.1 %
S
SKALLUM AS
Ordinary shares
43,000
0.1 %
Ordinary shares
41,346
0.09 %
2
2M-INVEST AS
Ordinary shares
40,500
0.09 %
Ordinary shares
40,089
0.09 %
Ordinary shares
40,000
0.09 %
O
OED INVEST AS
Ordinary shares
40,000
0.09 %
F
FINVESTIGA AS
Ordinary shares
40,000
0.09 %
Ordinary shares
40,000
0.09 %
Ordinary shares
40,000
0.09 %
Ordinary shares
40,000
0.09 %
F
FRENISA AS
Ordinary shares
40,000
0.09 %
P
PATRONIA AS
Ordinary shares
39,157
0.09 %
O
ORAKEL AS
Ordinary shares
37,591
0.08 %
R
REWAL AS
Ordinary shares
35,259
0.08 %
S
STRØ AS
Ordinary shares
35,000
0.08 %
Ordinary shares
35,000
0.08 %
Ordinary shares
35,000
0.08 %

Shares owned by the VISTIN PHARMA ASA

NameShare classTotal number of sharesShare
V
VISTIN PHARMA AS
Ordinary shares
50,000
100 %
Last update: Sep 25, 2026

Group structure

  • Total operating income 2025: NOK 0
    Operating profit 2025: NOK -5,155,000
    Employees: 0

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
0
0
0
0
0
Annual Total Result
10,989,000
-3,526,000
-2,984,000
-1,852,000
-2,558,000
Total assets
142,210,000
186,589,000
266,244,000
269,084,000
277,810,000
Total liabilities
2,617,000
2,554,000
1,096,000
953,000
7,829,000
Total equity
139,593,000
184,035,000
265,148,000
268,132,000
269,983,000

P&L

Year20252024202320222021
Total operating income
0
0
0
0
0
Total operating costs
5,155,000
6,052,000
6,978,000
4,194,000
4,698,000
Operating result
-5,155,000
-6,052,000
-6,978,000
-4,194,000
-4,698,000
Financial income/costs
19,243,000
1,532,000
3,152,000
1,820,000
1,419,000
Profit before tax
14,088,000
-4,520,000
-3,826,000
-2,374,000
-3,279,000
Total tax & extraordinary income/cost
3,099,000
-994,000
-842,000
-522,000
-721,000
Annual Total Result
10,989,000
-3,526,000
-2,984,000
-1,852,000
-2,558,000

Balance overview

Year20252024202320222021
Total fixed assets
51,413,000
54,857,000
113,113,000
108,112,000
107,590,000
Total current assets
90,797,000
131,732,000
153,131,000
160,972,000
170,220,000
Total assets
142,210,000
186,589,000
266,244,000
269,084,000
277,810,000
Short term debt
2,617,000
2,554,000
1,096,000
953,000
7,829,000
Long term debt
0
0
0
0
0
Total liabilities
2,617,000
2,554,000
1,096,000
953,000
7,829,000
Contributed capital
118,212,000
184,035,000
265,148,000
268,132,000
269,983,000
Retained earnings
21,381,000
0
0
0
0
Total equity
139,593,000
184,035,000
265,148,000
268,132,000
269,983,000
Total equity and liabilities
142,210,000
186,589,000
266,244,000
269,085,000
277,812,000

Classification

21st company classification
BETA
Scaleup
Category
Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2
Main industrial group
Manufacture of pharmaceutical preparations
21.20
Industrial group
Manufacture of pharmaceutical preparations
21.200
Industrial group
Manufacture of pharmaceutical preparations